New Retina Radio by Eyetube

New Retina Radio is a place to hear stories about retina that are told nowhere else.

Fellow Eye RRD Risk per IRIS Registry
May 8, 2025 – 16:42
Rates of Ocular AEs After Faricimab Injection
Mar 21, 2025 – 18:13
Treating Geographic Atrophy (GA) In Your Practice
Mar 5, 2025 – 19:18
Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy
Mar 5, 2025 – 22:07
Using OCT Angiography to Distinguish RVO and RAO
Jan 9, 2025 – 17:36
OCT Angiography in a Real-world CSR Case
Jan 9, 2025 – 17:59
Switching from Aflibercept to Faricimab in Wet AMD Patients
Dec 19, 2024 – 22:00
GA Options in Clinical Therapy: Which Patients Are a Fit for GA Treatment?
Dec 12, 2024 – 16:50
AAO '24: Real-world PDR Treatment vs. Protocol S Guidelines, and Retinal Imaging for Alzheimer's
Dec 5, 2024 – 31:38
New Retina Radio Journal Club w/ VBS: Does Metformin Reduce AMD Risk?
Nov 21, 2024 – 15:01
AAO '24 Late-Breakers: Preventing Fas Activation Prior to RRD Repair, and Phase 2/3 Data on an Oral Therapy for GA
Nov 14, 2024 – 20:02
AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD
Nov 7, 2024 – 25:27
AAO '24: COVID and Retinal Disease, Plus the Latest on Step Therapy and Declining Reimbursement
Oct 31, 2024 – 31:12
GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?
Oct 28, 2024 – 22:50
New Retina Radio Journal Club with VBS: Pre-treatment with Chlorhexidine vs. Povidone-Iodine in Endophthalmitis Prevention
Oct 17, 2024 – 16:59
Real-World Studies Reported in Lisbon: Untreated GA Progression and High-Dose Aflibercept in Wet AMD, DME, and DR
Oct 9, 2024 – 28:42
New Retina Radio Journal Club w/ VBS: Risk of Death, Stroke, and MI After RAO
Sep 17, 2024 – 16:15
ASRS ’24: C1q Inhibition and Metformin for AMD
Sep 5, 2024 – 23:43
New Retina Radio Journal Club with VBS: Switching to Faricimab in Wet AMD Patients With a History of Anti-VEGF Therapy
Aug 29, 2024 – 17:41
ASRS ’24: PAVILION at 100 Weeks
Aug 22, 2024 – 07:47
ASRS ’24: ACP in Patients with Major EZ Attenuation, and GALE Microperimetry Findings
Aug 8, 2024 – 16:16
New Retina Radio Journal Club w/ VBS: Risk Factors for Switching from Bevacizumab to Aflibercept in Protocol AC
Jul 19, 2024 – 19:37
From Trials to the Clinic: Using a Therapy With a Novel MOA to Treat Patients With DME
Jul 11, 2024 – 29:41
New Retina Radio Journal Club w/ VBS: RVOs During the COVID Pandemic
Jun 27, 2024 – 15:15
A Treatment With a Novel MOA for Patients With nAMD and DME: Perspectives From the Real World
Jun 20, 2024 – 34:24
AMD and DME Applications in the Retina Practice: Real-world Data
Jun 17, 2024 – 21:08
ARVO 2024 Coverage: UWF Leakage in Protocol AA, Machine Learning, and GA's Link to Anxiety/Depression
Jun 5, 2024 – 22:55
New Retina Radio Journal Club with VBS: New Retina Radio Journal Club with VBS: Is Buckling Effective for RRD in Patients at Risk for PVR?
May 29, 2024 – 13:57
ARVO 2024 Coverage: ≥20-week Dosing in PULSAR and TENAYA/LUCERNE
May 17, 2024 – 16:00
GA Options in Clinical Therapy, Part 2: Real-world Cases in GA
May 10, 2024 – 17:20
GA Options in Clinical Therapy, Part 1: Patient Selection and Treatment Strategies
May 10, 2024 – 23:42
AMD and DME Applications in the Retina Practice: RCT Comparison
May 8, 2024 – 21:13
The State of Biosimilars: Integration of Biosimilars into a Retina Practice
Apr 25, 2024 – 22:03
New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT
Apr 19, 2024 – 15:48
Successful Management of Vitreous Opacities
Apr 2, 2024 – 25:38
New Retina Radio Journal Club with VBS: Visual Outcomes Following Surgical RRD Repair Relative to Foveal Status and Time of Surgery
Mar 28, 2024 – 20:17
The State of Biosimilars: How We Got Here and What It Means for Practice
Feb 22, 2024 – 25:19
Cherchez la Femme Revisited
Feb 16, 2024 – 39:11
AAO ’23: Downward Trends in Reimbursement and ChatGPT in the Retina Clinic
Dec 14, 2023 – 35:53
New Retina Radio Journal Club: Intentional Suspension of Therapy in Wet AMD
Dec 7, 2023 – 15:32
AAO ’23: Real-World Faricimab Patterns and Improving GA Assessments
Nov 30, 2023 – 22:13
New Retina Radio AAO Late-Breakers: PULSAR at 96 Weeks and Home OCT in Wet AMD
Nov 22, 2023 – 25:59
New Retina Radio Journal Club: Prophylactic Laser for Lattice Degeneration in Fellow Eyes After RRD Repair
Nov 21, 2023 – 16:44
New Retina Radio AAO Late-Breakers: ALTITUDE and DIAMOND
Nov 13, 2023 – 21:16
New Retina Radio Journal Club: Are Postpartum Retinal Detachment Rates Linked to Method of Delivery?
Oct 26, 2023 – 16:58
Chronic Postoperative Inflammation: Patient Scenarios
Oct 5, 2023 – 21:16
New Retina Radio Journal Club: Cost Evaluation in DME Therapy
Sep 28, 2023 – 15:25
How Imaging Helps Clinics Integrate New Therapies in GA
Sep 25, 2023 – 16:26
Luminaries in Retina: Kirk Packo, MD, FACS (Part 2)
Sep 22, 2023 – 35:07
Luminaries in Retina: Kirk Packo, MD, FACS (Part 1)
Sep 22, 2023 – 40:27

Recent Reviews

Champ0506

Depressing

I have yet to hear information regarding retinitis pigmentosa! 😩 have advanced arRP. Need stem cell and crisper. Rare gene (RP59) small enough for gene therapy but I’m too advanced for gene therapy. Traveled all over the world, including Japan. Will do ANYTHING to be in a clinical trial. Please help. Only 37.
Landon Hawkins

June 22, 2020 podcast!!!

The one about $LCTX is very interesting!!
Steve H MD

NRR rocks!

Awesome podcast! Very relevant for retina surgeons. John Kitchens is a master interviewer and moderator.